Coping with prescription charges in the UK

International Journal of Pharmacy Practice

Volumn 12, Issue 4, 2004, Pages 239-246

  Schafheutle, Ellen I ^a   Hassell, Karen ^a   Noyce, Peter R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

ADULT; ARTICLE; CONSULTATION; DRUG COST; DYSPEPSIA; FEMALE; GENERAL PRACTICE; HEALTH CARE COST; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF MEDICATION; UNITED KINGDOM;

EID: 9644254414     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044995     Document Type: Article

References (49)

1. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med 1987;317:550-6.
2. Stuart B, Grana J. Ability to pay and the decision to medicate. Med Care 1998;36:202-11.
3. Blustein J. Drug coverage and drug purchases by Medicare beneficiaries with hypertension. Health Aff (Millwood) 2000;19:219-30.
4. O'Brien B. The effect of patient charges on the utilization of prescription medicines. J Health Econ 1989;8:109-32.
5. Ryan M, Birch S. Charging for health care: evidence on the utilisation of NHS prescribed drugs. Soc Sci Med 1991;33:681-7.
6. Hughes D, McGuire A. Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure. Health Econ 1995;4:213-20.
7. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effect of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994;331:650-5.
8. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
9. Noyce PR, Huttin C, Atella V, Brenner G, Haaijer-Ruskamp FM, Hedvall M, Mechtler R. The cost of prescription medicines to patients. Health Policy 2000;52:129-45.
10. National minimum wage. Department of Trade and Industry; 2003. www.dti.gov.uk/er/nmw/index.htm (accessed 6 October, 2004).
11. The Future of Prescribing. Discussion Paper. March 2001. London: The BMA General Practitioners' Committee (GPC); 2001.
12. Phelps L. Unhealthy Charges. CAB evidence on the impact of health charges. London: National Association of Citizens Advice Bureaux; 2001.
13. Prescriptions dispensed in the community. Statistics for 1992 to 2002: England. Statistical bulletin. London: Department of Health; 2003.
14. Huttin C. Patient charges and decision making behaviours of consumers and physicians. Amsterdam: IOS Press; 2003.
15. Weiss MC, Hassell K, Schafheutle EI, Noyce PR. Strategies used by general practitioners to minimise the impact of the prescription charge. Eur J Gen Pract 2001;7:23-6.
16. Schafheutle EI, Hassell K, Noyce PR Weiss MC. Access to medicines: cost as an influence on the views and behaviour of patients. Health Soc Care Community 2002;10:187-95.
17. National Centre for Social Research and University College London. Department of Epidemiology and Public Health, Health Survey for England, 1999 [computer file]. 3rd Edition. Colchester, Essex: UK Data Archive [distributor]; February 2002. SN: 4365. www.data-archive.ac.uk/doc/ 4365/mrdoc/UKDA/ UKDA_Study_4365_Information.htm (accessed 22 September, 2004).
18. Department of Health. National Survey of NHS Patients; 1998. www.dh.gov.uk/PublicationsAndStatistics/Published Survey/ NationalSurveyOfNHSPatients/fs/en (accessed 22 September, 2004).
19. The Health Education Authority. Survey of Activity and Health; 1990. http://qb.soc.surrey.ac.uk/surveys/sah/sah90. htm (accessed 22 September, 2004).
20. McInnes GT. Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J 1999;138:S252-S255.
21. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-2.
22. Norman GR, Steiner DL. Biostatistics: the bare essentials. St Louis: Mosby; 1994.
23. Office for National Statistics. Social Trends 30, 2000 edition. London: The Stationery Office; 2000.
24. Begg D. Do patients cash their prescriptions? An audit in one practice. J R Coll Gen Pract 1984;34:272-4.
25. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993;307:846-8.
26. Jones I, Britten N. Why do some patients not cash their prescriptions? Br J Gen Pract 1998;48:903-5.
27. Schafheutle EI, Hassell K, Seston EM, Noyce PR. Non-dispensing of NHS prescriptions in community pharmacies. Int J Pharm Pract 2002;10:11-15.
28. Payne K, Ryan-Woolley BM, Noyce PR. Role of consumer attributes in predicting the impact of medicines deregulation on National Health Service prescribing in the United Kingdom. Int J Pharm Pract 1998;6:150-8.
29. Schafheutle EI, Cantrill JA, Nicolson M, Noyce PR. Insights into the choice between self-medication and a doctor's prescription: a study of hay fever sufferers. Int J Pharm Pract 1996;4:156-61.
30. Hassell K, Atella V, Schafheutle EI, Weiss MC, Noyce PR. Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison. Eur J Pub Health 2003;13:18-23.
31. Smith F. Health services research methods in pharmacy. Survey research: (1) Design, samples and response. Int J Pharm Pract 1997;5:152-66.
32. Strickland WJ, Hanson CM. Coping with the cost of prescription drugs. J Health Care Poor Underserved 1996;7:50-62.
33. Cox ER, Jernigan C, Joel Coons SJ, Draugalis JR. Medicare beneficiaries' management of capped prescription benefits. Med Care 2001:39:296-301.
34. Cox ER, Henderson RR. Prescription use behaviour among Medicare beneficiaries with capped prescription benefits. J Manag Care Pharm 2002;8:360-4.
35. Harris Interactive. Higher out-of-pocket costs cause massive non-compliance in the use of prescription drugs, and this is likely to grow. Health Care News 2002;2:1-3. www.harris-interactive.com (accessed 15 September, 2004).
36. Elliott R, Barber N, Noyce P. Can Britain and the United States learn anything from each other? Pharm J 2003;271:508-10.
37. Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N. Patients' unvoiced agendas in general practice consultations: qualitative study. BMJ 2000;320:1246-50.
38. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003;290:953-8.
39. Bissell P, Ward PR, Noyce PR. Variation within community pharmacy. 3. Referring customers to other health professionals. J Soc Admin Pharm 1997;14:116-23.
40. Hassell K, Noyce PR, Rogers A. A review of factors that influence the use of community pharmacies as a primary health care resource. Int J Pharm Pract 1999;7:51-9.
41. Pharmacy in the future - implementing the NHS Plan. London: Department of Health; 2000.
42. Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme. Room for review. London: Medicines Partnership; 2003.
43. National Service Framework for Coronary Heart Disease. London: Department of Health; 2000. www.dh.gov.uk/ assetRoot/04/04/90/70/04049070.pdf (accessed 22 September, 2004).
44. Federman AD. Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA 2001;286:1732-9.
45. Smeet L, Heath I. Why inequalities in health matter to primary care. Br J Gen Pract 2001;51:436-7.
46. Health and Social Services: press release. Free prescriptions on their way for the people of Wales, Jane Hutt announces. www.wales.gov.uk/assemblydata/ N0000000000000000000000000012808.htm (accessed 15 September, 2004).
47. Andalo D. Why the government accepts the hit and miss nature of prescription charges. Pharm J 2002;268:833-4.
48. www.ppa.org.uk/ppa/low_income.htm (accessed 20 September, 2004)
49. Neal RD, Heywood PL, Morley S. Frequent attenders' consulting patterns with general practitioners. Br J Gen Pract 2000;50:972-6.